Keith A. Goldan
CIK 1495411 · Chief Financial Officer · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.67M
Companies
5
Total Filings
40
Lifetime Open-Market Net
-$196.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SNDX | Chief Financial Officer | 139,252 | $20.37 | $2.84M | -$195.4K | 14 | 2026-06-02 |
| ABEO | Director | 32,751 | $7.45 | $244.0K | $0 | 1 | 2026-04-07 |
| OptiNose, Inc. (OPTN) Delisted | Chief Financial Officer | 9,448 | $9.60 | $90.7K | -$13.7K | 13 | 2022-03-17 |
| Fibrocell Science, Inc. (FCSC) Delisted | SVP and CFO | 133 | — | — | $12.7K | 2 | 2016-03-02 |
| PATH | CFO and VP | 166,066 | $15.59 | $2.59M | $0 | 4 | 2013-01-22 |
Recent Filings · Page 3 of 4
40 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −4,617 | -$9.7K | EDGAR |
| 2022-01-12 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +56,730 | $0 | EDGAR |
| 2021-12-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −580 | -$951 | EDGAR |
| 2021-09-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −578 | -$1.6K | EDGAR |
| 2021-06-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −576 | -$2.1K | EDGAR |
| 2021-03-17 | OptiNose, Inc. (OPTN) Delisted | Sell (S) | −2,304 | -$9.0K | EDGAR |
| 2021-03-17 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +30,567 | $0 | EDGAR |
| 2021-03-08 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | +53,333 | $0 | EDGAR |
| 2020-09-23 | OptiNose, Inc. (OPTN) Delisted | Buy (P) | +2,500 | $9.7K | EDGAR |
| 2020-03-09 | OptiNose, Inc. (OPTN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.